NCT06230718 EMG Analysis in ABI: Motor Imagery and Action
| NCT ID | NCT06230718 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Salamanca |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 28 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2026-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 28 participants in total. It began in 2024-01-01 with a primary completion date of 2026-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study focuses on electromyographic analysis of upper limb muscle activation in stroke survivors during Motor Imagery (MI) and Action Observation (AO) rehabilitation techniques. By measuring muscle activity in the wrist and finger flexors and extensors, the research seeks to understand the impact of MI and AO on motor function recovery post-stroke. Conducted at the University of Salamanca, the study involves stroke survivors participating in a series of three experimental sessions. The analysis will correlate electromyographic responses with functional independence, limb functionality, and cognitive factors. The research aims to contribute to the fields of occupational therapy and physiotherapy, offering insights into effective rehabilitation methods for improving quality of life in stroke survivors.
Eligibility Criteria
Inclusion Criteria: * Being over 18 years of age * Diagnoses of established stroke * Present limitations or motor response deficiencies in the upper limb * Maintain cognitive functions with the ability to follow the instructions of the interventions and evaluations (MOCA\>14) Exclusion Criteria: * Diagnosed with mental illness before the stroke * Other systemic conditions on the central nervous system * Cardiorespiratory system pathologies in severe cases * Acute period, fever, muscle inflammation or myopathies * Any type of vascular and organic insufficiency * Liver disease or skin lesions in the area of application of the electrodes.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06230718 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06230718 currently recruiting?
Yes, NCT06230718 is actively recruiting participants. Contact the research team at beatriz.bermejo@usal.es for enrollment information.
Where is the NCT06230718 trial being conducted?
This trial is being conducted at Salamanca, Spain.
Who is sponsoring the NCT06230718 clinical trial?
NCT06230718 is sponsored by University of Salamanca. The trial plans to enroll 28 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.